SCHEMBL357806

SCHEMBL357806

NC(=O)Nc1ccc2c(c1)OCCCO2

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.61
CYP2C19 P33261 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
NPC1 O15118 9/20 0.59
RAB9A P51151 8/20 0.59
SMN1; SMN2 Q16637 6/20 0.59
KMT2A Q03164 6/20 0.59
MAPT P10636 4/20 0.59
MEN1 O00255 4/20 0.59
POLB P06746 3/20 0.59
NFKB1 P19838 2/20 0.59
NFKB2 Q00653 2/20 0.59
RELA Q04206 2/20 0.59
KDM4E B2RXH2 1/20 0.57
GAA P10253 2/20 0.56
ALDH1A1 P00352 4/20 0.55
MAPK1 P28482 1/20 0.54
HPGD P15428 1/20 0.54
TP53 P04637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29242622 0.93 CYP1A2 (0.70) CYP1A2CYP2C19NPSR1NPC1RAB9A
SCHEMBL14499419 0.89 MAPT (0.72) CYP1A2CYP2C19NPSR1NPC1RAB9A
SCHEMBL14499420 0.89 MAPT (0.72) CYP1A2CYP2C19NPSR1NPC1RAB9A
SCHEMBL1383868 0.86 NPC1 (0.74) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL12611073 0.85 CYP1A2 (0.63) CYP1A2CYP2C19NPSR1NPC1RAB9A
SCHEMBL10848884 0.83 CYP1A2 (0.87) CYP1A2CYP2C19NPSR1NPC1RAB9A
SCHEMBL8188470 0.81 NPC1 (0.66) CYP1A2CYP2C19NPSR1NPC1RAB9A
SCHEMBL12308327 0.80 HSD17B10 (0.63) CYP1A2CYP2C19NPSR1NPC1RAB9A
SCHEMBL17776530 0.80 GAA (0.88) CYP1A2CYP2C19NPSR1NPC1RAB9A
SCHEMBL788995 0.79 SMN1; SMN2 (0.81) CYP1A2CYP2C19NPSR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013211-B1 PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS NOVARTIS AG (CH) 2012-03-14 EP disclosed
WO-2007121920-A2 PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS NOVARTIS AG (CH) 2007-11-01 WO disclosed